Kasi PM - Search Results

1

Neoadjuvant immunotherapy for dMMR and pMMR colorectal cancers: therapeutic strategies and putative biomarkers of response.

Williams CJM, Peddle AM, Kasi PM, Seligmann JF, Roxburgh CS, Middleton GW, Tejpar S. Williams CJM, et al. Among authors: kasi pm. Nat Rev Clin Oncol. 2024 Dec;21(12):839-851. doi: 10.1038/s41571-024-00943-6. Epub 2024 Sep 24. Nat Rev Clin Oncol. 2024. PMID: 39317818 Review.

2

Author Correction: Neoadjuvant immunotherapy for dMMR and pMMR colorectal cancers: therapeutic strategies and putative biomarkers of response.

Williams CJM, Peddle AM, Kasi PM, Seligmann JF, Roxburgh CS, Middleton GW, Tejpar S. Williams CJM, et al. Among authors: kasi pm. Nat Rev Clin Oncol. 2024 Dec;21(12):903. doi: 10.1038/s41571-024-00955-2. Nat Rev Clin Oncol. 2024. PMID: 39375554 No abstract available.

3

Author Correction: Genetic features and therapeutic relevance of emergent circulating tumor DNA alterations in refractory non-colorectal gastrointestinal cancers.

Hsiehchen D, Bucheit L, Yang D, Beg MS, Lim M, Lee SS, Kasi PM, Kaseb AO, Zhu H. Hsiehchen D, et al. Among authors: kasi pm. Nat Commun. 2023 Nov 22;14(1):7621. doi: 10.1038/s41467-023-43052-1. Nat Commun. 2023. PMID: 37993437 Free PMC article. No abstract available.

4

Circulating Tumor DNA Response and Minimal Residual Disease Assessment in DNA Polymerase Epsilon-Mutated Colorectal Cancer Undergoing Immunotherapy.

Lutfi A, Afghan MK, Kasi PM. Lutfi A, et al. Among authors: kasi pm. Cureus. 2023 Aug 12;15(8):e43391. doi: 10.7759/cureus.43391. eCollection 2023 Aug. Cureus. 2023. PMID: 37593074 Free PMC article.

5

Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumors.

Reduzzi C, Nicolo' E, Singhal S, Venetis K, Ortega-Franco A, de Miguel-Perez D, Dipasquale A, Gouda MA, Saldanha EF, Kasi PM, Jantus-Lewintre E, Fusco N, Malapelle U, Gandara DR, Rolfo C, Serrano MJ, Cristofanilli M; International Society of Liquid Biopsy (ISLB). Reduzzi C, et al. Among authors: kasi pm. Crit Rev Oncol Hematol. 2024 Nov;203:104483. doi: 10.1016/j.critrevonc.2024.104483. Epub 2024 Aug 17. Crit Rev Oncol Hematol. 2024. PMID: 39159706 Review.

6

Circulating tumour cell enumeration, biomarker analyses, and kinetics in patients with colorectal cancer and other GI malignancies.

Malkawi W, Lutfi A, Afghan MK, Shah LM, Costandy L, Ramirez AB, George TC, Toor F, Salem AK, Kasi PM. Malkawi W, et al. Among authors: kasi pm. Front Oncol. 2023 Nov 17;13:1305181. doi: 10.3389/fonc.2023.1305181. eCollection 2023. Front Oncol. 2023. PMID: 38044994 Free PMC article.

7

Editorial: Case reports in gastrointestinal cancers : 2022.

Kasi PM. Kasi PM. Front Oncol. 2023 Nov 16;13:1333174. doi: 10.3389/fonc.2023.1333174. eCollection 2023. Front Oncol. 2023. PMID: 38044997 Free PMC article. No abstract available.

8

Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study.

Strickler JH, Cercek A, Siena S, André T, Ng K, Van Cutsem E, Wu C, Paulson AS, Hubbard JM, Coveler AL, Fountzilas C, Kardosh A, Kasi PM, Lenz HJ, Ciombor KK, Elez E, Bajor DL, Cremolini C, Sanchez F, Stecher M, Feng W, Bekaii-Saab TS; MOUNTAINEER investigators. Strickler JH, et al. Among authors: kasi pm. Lancet Oncol. 2023 May;24(5):496-508. doi: 10.1016/S1470-2045(23)00150-X. Lancet Oncol. 2023. PMID: 37142372 Clinical Trial.

9

Durvalumab-Induced Immune Thrombocytopenia in Patients with Advanced Cholangiocarcinoma Undergoing Yttrium-90 Radioembolization.

Afghan MK, Lutfi A, Qadri F, Khan S, Javaid S, Currie BM, Rocca JP, Samstein B, Hissong E, Kasi PM. Afghan MK, et al. Among authors: kasi pm. Case Rep Oncol. 2024 Oct 18;17(1):1183-1193. doi: 10.1159/000541550. eCollection 2024 Jan-Dec. Case Rep Oncol. 2024. PMID: 39474535 Free PMC article.

10

Circulating Tumor DNA Profiling of Advanced Biliary Tract Cancers.

Mody K, Kasi PM, Yang J, Surapaneni PK, Bekaii-Saab T, Ahn DH, Mahipal A, Sonbol MB, Starr JS, Roberts A, Nagy R, Lanman R, Borad MJ. Mody K, et al. Among authors: kasi pm. JCO Precis Oncol. 2019 Dec;3:1-9. doi: 10.1200/PO.18.00324. JCO Precis Oncol. 2019. PMID: 35100741

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

149 results

Search Page

Filters